Janice Brown
Clinical Trials
- Recruiting Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
- Recruiting Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
- Recruiting Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
- Recruiting Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidate Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
- Not Recruiting Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects
- Not Recruiting An Observational Study of Fungal Biomarkers (MK-0000-089 AM3)
- Not Recruiting A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)
- Not Recruiting Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
- Not Recruiting Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients
- Not Recruiting A Study of an Investigational V212/Heat-Treated VZV Vaccine in Immunocompromised Adults
- Recruiting A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3)
- Recruiting A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (Study No. V212-001 AM4)
